Oracle Launches AI Data Platform for Life Sciences Research

February 02, 2026
Oracle has introduced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to unify and analyze large-scale health data to support pharmaceutical, medical device, and research organizations.

Oracle announced in a press release the launch of its Oracle Life Sciences AI Data Platform, a generative AI-driven analytics solution aimed at accelerating research and development, clinical trials, and commercialization for pharmaceutical, medical device, and life sciences organizations.

The platform combines proprietary and third-party data with more than 129 million de-identified longitudinal records from Oracle Health Real-World Data. It uses generative AI and agentic reasoning to interpret information and deliver actionable insights within research and clinical workflows.

Organizations can use built-in AI agents or create their own to perform tasks such as identifying label expansion opportunities, conducting Health Economics and Outcomes Research, generating synthetic control arms, and monitoring safety data. The system also allows researchers to ask open-ended questions, refine hypotheses, and track data lineage.

The platform integrates with Oracle Cloud Infrastructure, Oracle Life Sciences AI Application Suite, Oracle Fusion Cloud SCM, Oracle Fusion Cloud Sales, and Oracle Health AI Application Suite, providing a unified environment for life sciences operations. Oracle Corporation will showcase the platform at the SCOPE conference in Orlando, Florida, from February 2–5, 2026.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

02/02
XtalPi Introduces AI-Powered XGlue Platform for Molecular Glue Drug Discovery
02/02
Nucs AI Forms Medical Advisory Board for AI-Driven Theranostics
02/02
Healthcare Triangle Partners with Better.care to Expand Health Data Platforms Across EMEA
01/28
Viveka Health Earns HITRUST e1 Certification with Support from Palindrome Technologies
01/21
EyeContactDX Appoints Dr. Carol Weitzman as Senior Strategic Advisor for AI Autism Screening

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like